Skip to content
Home/Companies/Biotech/Amal Therapeutics

Amal Therapeutics

Biotech·Switzerland·Exited 2019·Held 5yr
Entry
2014
Hold
5yr
Exit
2019

Who owns Amal Therapeutics?

Amal Therapeutics was owned by High-Tech Gruenderfonds (HTGF) through HTGF II (2011 vintage) from 2014 to 2019, exited via Trade Sale. Across its history, Amal Therapeutics has been through 2 private equity ownership periods, detailed in the timeline below.

Buyer identity available on Pro.

Hand-verified · updated 2026-07-07

High-Tech Gruenderfonds (HTGF)
Most recent investor
High-Tech Gruenderfonds (HTGF)
HTGF II · 2011 · VC
2 ownership periods · full history below

Key facts

HQSwitzerland
SectorBiotech
StatusAcquired
Key takeaways
  • ·Fully exited in 2019.
  • ·Average hold across 2 realized cycles: 4 years.

Ownership history

2 ownership periods · co-invest detected

Exited
Last exited in 2019 to .
Co-invest · 2 holders · 2014 · 2019
High-Tech Gruenderfonds (HTGF)
High-Tech Gruenderfonds (HTGF)Exited 2019
2014 · 2019(5yr) · HTGF II · 2011 · VC
Trade Sale · to
MOIC
–
Boehringer Ingelheim Venture Fund
Boehringer Ingelheim Venture FundExited 2019
2016 · 2019(3yr) · Boehringer Ingelheim Venture Fund · 2010 · Evergreen
Trade Sale · to
MOIC
–

More from HTGF II

Other portfolio companies in the same fund.

Adlatus Robotics
Adlatus Robotics
Active
IndustrialsGermany· 2016
Adtriba
Active
AdTechGermany· 2016
casavi
casavi
Active
PropTechGermany· 2016
Cognigy
Cognigy
Exited 2025
AI/MLGermany· 2016
to
CommSolid
Exited 2018
Deep TechGermany· 2016
to
Cycle
Cycle
Active
SaaSGermany· 2016

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Aldevron
Aldevron
Active
TA AssociatesUS
Antiverse
Antiverse
Active
Future Planet CapitalUK
CellCentric
CellCentric
Active
Future Planet CapitalUK
Crescendo Biologics
Crescendo Biologics
Active
Future Planet CapitalUK
Cytox Group
Exited 2024
Future Planet CapitalUK
Elkedonia
Elkedonia
Active
Capital Grand EstFrance
Track Amal Therapeutics

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy Amal Therapeutics?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on Amal Therapeutics.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue